Varta
← Back to stories

From The Economic Times

Center-Right Owned by Bennett, Coleman & Co.

NPPA updates list of reduced MRP of 1,085 anti-cancer drugs

NPPA updates list of reduced MRP of 1,085 anti-cancer drugs

What each side is saying

One outlet's own words from each side of the spectrum. Quoted, not summarised.

  • right · 2 outlets

    The National Pharmaceutical Pricing Authority updated the maximum retail price for 1,085 anti-cancer medicines. This revision follows a previous decrease of prices for 543 anti-cancer drugs announced on October 28. The updated list contains prices based on information submitted by pharmaceutical…

    — The Economic Times

RSS excerpt

The National Pharmaceutical Pricing Authority updated the maximum retail price for 1,085 anti-cancer medicines. This revision follows a previous decrease of prices for 543 anti-cancer drugs announced on October 28. The updated list contains prices based on information submitted by pharmaceutical…

Coverage arrived over 9 hours — first from The Economic Times, latest from The Hindu BusinessLine.

✓ Corroborated Coverage 2 news outlets reporting

Fact-Check & Bias Analysis

Reported by multiple independent newsrooms.

Coverage Bias Distribution

Based on 2 reporting publishers
Left / Center-Left 0 (0%)
Center 0 (0%)
Center-Right / Right 2 (100%)

Compare all reporting outlets (2)

The Economic Times Center-Right Bennett, Coleman & Co. Current article

NPPA updates list of reduced MRP of 1,085 anti-cancer drugs

The National Pharmaceutical Pricing Authority updated the maximum retail price for 1,085 anti-cancer medicines. This revision follows a previous decrease of prices for 543 anti-cancer drugs announced on October 28. The updated list contains prices based on information submitted by pharmaceutical…

Read full article at The Economic Times ↗

Read more news

See all latest stories →